从“盲目轰炸”到“精准打击”:肺癌30年治疗方式革新( 三 )


[6]. Nivolumabplus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl JMed. 2018 May 31;378(22):2093-2104.
[7]. Camrelizumab(SHR-1210) alone or in combination with gemcitabine plus cisplati
【从“盲目轰炸”到“精准打击”:肺癌30年治疗方式革新】CN-70617